Progesterone Capsule
Product Images NDC 76420-267

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 76420-267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure 1)

A line chart showing the probability of hyperplasia over 36 months on medication. The x-axis represents time in months (0, 12, 24, 36) and the y-axis represents the probability of hyperplasia from 0.0 to 1.0. Three groups are compared: Conjugated Estrogens Alone, Conjugated Estrogens Plus Micronized Progesterone (cyclical), and Placebo Only. The number of patients remaining at each interval is indicated below the x-axis.*

FDA Label Image

Label (Lbl 100mg Label)

The image displays multiple labels for Progesterone Capsules 100 mg in quantities of 10, 30, 60, 90, and 100. Each label shows packaging by Enovachem Pharmaceuticals, with addresses in Torrance, CA, and includes NDC numbers specific to each quantity. The capsules are described as off-white/ovoid, packaged for Northstar Rx LLC.*

FDA Label Image

Chemical Structure (Prog Structure)

Chemical structure of progesterone, a steroid hormone molecule depicted in a diagram showing rings and functional groups typical of its chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.